Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Berger

Showing results (41-50 of 134) with videos related to

Pageof 14
Sort By:
The American Journal of Psychiatry|December 1, 1979
Choline chloride in schizophreniaK L Davis, L E Hollister, P A Berger
Communications in Psychopharmacology|January 1, 1980
Apomorphine in schizophreniaL E Hollister, K L Davis, P A Berger
Psychopharmacology Communications|January 1, 1975
Butaclamol hydrochloride in newly admitted schizophrenicsL E Hollister, K L Davis, P A Berger
Biological Psychiatry|April 15, 1988
Olfactory deficits and Down's syndromeM D Warner, C A Peabody, P A Berger
Biological Psychiatry|February 1, 1985
Plasma testosterone levels, depression, sexuality, and ageJ A Yesavage, J Davidson, L Widrow, et al.
Biological Psychiatry|April 1, 1977
Coexisting tardive dyskinesia and parkinsonism: a case reportE G De Fraites, K L Davis, P A Berger
Archives of General Psychiatry|January 1, 1978
Physostigmine in maniaK L Davis, P A Berger, L E Hollister, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1981
Clinical studies on the role of endorphins in schizophreniaP A Berger, S J Watson, H Akil, et al.
The New England Journal of Medicine|October 11, 1984
Treatment of Tourette's syndrome with RO22-1319, a D-2-receptor antagonistS B Uhr, P A Berger, B Pruitt, et al.
Psychopharmacology|May 25, 1979
Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disordersK L Davis, L E Hollister, J Livesey, et al.
Pageof 14

Showing results (41-50 of 134) with videos related to

Sort By:
Pageof 14
The American Journal of Psychiatry|December 1, 1979
Choline chloride in schizophreniaK L Davis, L E Hollister, P A Berger
Communications in Psychopharmacology|January 1, 1980
Apomorphine in schizophreniaL E Hollister, K L Davis, P A Berger
Psychopharmacology Communications|January 1, 1975
Butaclamol hydrochloride in newly admitted schizophrenicsL E Hollister, K L Davis, P A Berger
Biological Psychiatry|April 15, 1988
Olfactory deficits and Down's syndromeM D Warner, C A Peabody, P A Berger
Biological Psychiatry|February 1, 1985
Plasma testosterone levels, depression, sexuality, and ageJ A Yesavage, J Davidson, L Widrow, et al.
Biological Psychiatry|April 1, 1977
Coexisting tardive dyskinesia and parkinsonism: a case reportE G De Fraites, K L Davis, P A Berger
Archives of General Psychiatry|January 1, 1978
Physostigmine in maniaK L Davis, P A Berger, L E Hollister, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1981
Clinical studies on the role of endorphins in schizophreniaP A Berger, S J Watson, H Akil, et al.
The New England Journal of Medicine|October 11, 1984
Treatment of Tourette's syndrome with RO22-1319, a D-2-receptor antagonistS B Uhr, P A Berger, B Pruitt, et al.
Psychopharmacology|May 25, 1979
Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disordersK L Davis, L E Hollister, J Livesey, et al.
Pageof 14